Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03810352 · ClinicalTrials.gov registry record
Association of Platelet Parameters With Bleeding Severity in Children With ITP
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 95
- Enrollment target
NCT03810352 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 95 participants.
The verdict
NCT03810352 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 95 participants
- Enrollment target
Study Summary
Patients with severe immune thrombocytopenia (ITP) present with similarly low platelet counts but varying bleeding symptoms, making it difficult to predict the disease course and to decide on an appropriate treatment plan. In a single-center study, platelet parameters including the immature platelet fraction, the absolute immature platelet count , and functional response markers were found to be significantly associated with patient bleeding severity, independent of platelet count. This study aims to confirm and replicate these findings in a multi-center patient population and to investigate the use of these parameters to better predict disease severity and bleeding events.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2019-03-15 |
| Est. Completion | 2023-11-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03810352
The ClinicalTrials.gov registry entry for NCT03810352 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03810352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03810352 about?
NCT03810352 is a clinical study titled "Association of Platelet Parameters With Bleeding Severity in Children With ITP". Patients with severe immune thrombocytopenia (ITP) present with similarly low platelet counts but varying bleeding symptoms, making it difficult to predict the disease course and to decide on an appropriate treatment plan. In a single-center study, platelet parameters including the immature platelet...
What is the current status of trial NCT03810352?
This trial is currently completed. The enrollment target is 95 participants. The study started on 2019-03-15. Estimated completion is 2023-11-26.
Who is sponsoring clinical trial NCT03810352?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.